Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Dr David Cranston, Consultant Urological Surgeon, Clinical Director High Intensity Focused Ultrasound Unit, Nuffield Department of Surgical Sciences and Fellow Of Green Templeton College Oxford, has recently published the book "John Radcliffe and his Legacy to Oxford."

Book coverJohn Radcliffe is a name known to every Oxford resident. The hospital bears his name, and the Radcliffe Camera is but one monument to his legacy. But who was he? What sort of doctor was he, and whom did he treat? How did he manage to amass such a fortune and bestow his name and influence on so much of the city? David Cranston’s short book tells the story of John Radcliffe and the legacy he left behind.

Professor Sir David Watson, Principal, Green Templeton College commented: “John Radcliffe’s bequests have changed the face of historical Oxford, and their effects live on. Green Templeton College Fellow David Cranston has performed a valuable service, in the tercentenary year of the Doctor’s death, by showing how and why this came about.  As the College views the 21st century physical evolution of Oxford University, from the commanding heights of the Radcliffe Observatory, it is salutary to reflect on how science, medicine, management and architecture have made use of this legacy, and continue to do so through our work in education, research and public service.”

Sir Roger Bannister, a former Radcliffe Travelling Fellow said: “I am delighted as a physician to commend a book written by a surgeon about a physician. In 1960 I had the good fortune to benefit from one of John Radcliffe’s many acts of generosity to Oxford University. Holding a John Radcliffe Medical Travelling Fellowship, I spent a year at Harvard as part of my training to become a Consultant Neurologist. In the 18th century, Radcliffe Medical Fellows commonly went to the European centres of medical excellence, such as Bologna in Italy. That wise and robust sage, Dr Samuel Johnson, remarked that they and their patients might benefit more if they visited underdeveloped parts of the world such as South America, to study treatments and drugs outside Britain and Europe. Had they taken his advice, we might have benefited two centuries earlier from a wide range of drugs discovered in South America, such as curare”.

Further information: 

To order visit www.wordsbydesign.co.uk and follow the ‘books for sale’ link.

John Radcliffe and his Legacy to Oxford by David Cranston, with illustrations by Valerie Petts (ISBN: 978-1-909075-18-4)

Dr Cranston's webpage

Similar stories

PRINCIPLE Covid-19 treatments trial widens to under 50s and adds colchicine

Clinical Trials Coronavirus COVID-19 General Research

From today, the UK’s national priority platform trial of Covid-19 treatments for recovery at home launches its investigation of the gout drug colchicine, and expands for the first time to include adults of any age.

Singula Bio, a new Oxford spin-out company - Cancer need not be fatal

General Innovation Research

Singula Bio, a bold new seed-stage biotechnology company spun out of Oxford University, has been launched with the intention of helping show that cancer need not be fatal. Led by three Oxford cancer specialists, the firm is aims to become a world leader in therapies to use against difficult-to-treat solid malignancies such as ovarian cancer - using the body’s own immune system to fight previously fatal cancers.

Major rise in public support for COVID vaccine – Oxford study

Coronavirus COVID-19 General Research

More than three quarters of people in the UK now say they are ’very likely’ to have the vaccine – up from 50% among the same group of survey respondents five months ago –according to a two-wave Oxford University survey published today.

Coronavirus vaccination linked to substantial reduction in hospitalisation, real-world data suggests

Coronavirus COVID-19 General Research

The first study to describe the effects in real-world communities of the Oxford coronavirus vaccine has been reported in a pre-print publication today, showing a clear reduction in the risk of hospitalisation from COVID-19 amongst those who have received the vaccine.

World’s largest clinical trial for COVID-19 treatments expands internationally

Clinical Trials Coronavirus COVID-19 General

The Randomised Evaluation of COVID-19 Therapy (RECOVERY) Trial, the world’s largest clinical trial for COVID-19 treatments, has now expanded internationally with Indonesia and Nepal among the first countries to join. The first patients have been recruited to RECOVERY International.